Biominas has already carried out the prospection of new technologies/products early and late-stage for differentes pharmaceutical companies, such as Roche, GSK, Sanofi and Ferring. In all, there were approximately 500 technologies mapped in different areas via active prospecting and opening of notices. Some of the results obtained include partnerships with startups, universities and incorporation of new products/services into the company’s innovation pipeline.
Biominas Brasil is the executor of the Inovalabs program for the pre-acceleration of research projects at the Oswaldo Cruz Foundation. This initiative is the result of the partnership between Fiocruz and the DECIT-Ministry of Health and a central part of the institution’s innovation policy. The project started in 2019, with the forecast to end in 2020 with the training of +80 teams in 4 rounds of the program.
In 2019, Biominas Brasil was Roche’s official partner in the operation and execution of its corporate acceleration program, Astro. The initiative is part of the company’s innovation strategy, with the objectives of bringing pharmaceuticals closer to universities and accelerating the development of health research.
Av. José Cândido da Silveira, 2100 - Horto, Belo Horizonte - MG, 31035 - 536
+55 (31) 3303-0000